Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$233.45 - $247.73 $213,606 - $226,672
915 New
915 $226,000
Q3 2023

Oct 27, 2023

SELL
$254.9 - $283.59 $49,705 - $55,300
-195 Reduced 4.9%
3,786 $978,000
Q2 2023

Aug 02, 2023

BUY
$238.39 - $265.32 $11,681 - $13,000
49 Added 1.25%
3,981 $1.05 Million
Q1 2023

Apr 18, 2023

BUY
$229.71 - $259.35 $74,426 - $84,029
324 Added 8.98%
3,932 $973,000
Q4 2022

Jan 26, 2023

BUY
$218.29 - $256.91 $73,563 - $86,578
337 Added 10.3%
3,608 $0
Q3 2022

Oct 17, 2022

BUY
$51.03 - $264.23 $9,695 - $50,203
190 Added 6.17%
3,271 $729,000
Q2 2022

Jul 12, 2022

BUY
$234.74 - $275.42 $180,515 - $211,797
769 Added 33.26%
3,081 $760,000
Q1 2022

Apr 18, 2022

BUY
$243.64 - $270.48 $158,853 - $176,352
652 Added 39.28%
2,312 $608,000
Q4 2021

Jan 20, 2022

BUY
$230.08 - $250.94 $50,387 - $54,955
219 Added 15.2%
1,660 $417,000
Q3 2021

Oct 14, 2021

BUY
$232.72 - $256.47 $335,349 - $369,573
1,441 New
1,441 $354,000
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $233 - $256
-1 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$205.46 - $240.27 $3,287 - $3,844
-16 Reduced 94.12%
1 $1,000
Q2 2017

Aug 18, 2017

BUY
N/A
17
17 $2,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Archford Capital Strategies, LLC Portfolio

Follow Archford Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.